Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect01:26

Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...
Vaccinations01:51

Vaccinations

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Venous thromboembolism after mechanical restraint in psychiatric hospitals: population based cohort and self-controlled case series study.

BMJ (Clinical research ed.)·2026
Same author

Instrumental Variable Estimation of Marginal Structural Mean Models for Time-Varying Treatment.

Journal of the American Statistical Association·2026
Same author

Finding distributions that differ, with false discovery rate control.

Biometrika·2026
Same author

Global Sensitivity Analysis for Studies Extending Inferences From a Randomized Trial to a Target Population.

Statistics in medicine·2026
Same author

Identification and Estimation of Vaccine Effectiveness in the Test-Negative Design Under Equi-confounding.

Epidemiology (Cambridge, Mass.)·2025
Same author

[Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration - a Korean translation].

Ewha medical journal·2025

Related Experiment Video

Updated: May 25, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

A mapping between interactions and interference: implications for vaccine trials.

Tyler J VanderWeele1, Jan P Vandenbroucke, Eric J Tchetgen Tchetgen

  • 1Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. tvanderw@hsph.harvard.edu

Epidemiology (Cambridge, Mass.)
|February 10, 2012
PubMed
Summary
This summary is machine-generated.

This study links causal interactions to interference, showing empirical tests for one can detect the other. This framework helps identify spillover effects in areas like vaccine trials.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Related Experiment Videos

Last Updated: May 25, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Area of Science:

  • Epidemiology
  • Causal Inference
  • Statistical Methods

Background:

  • Interference occurs when one person's exposure affects another's outcomes.
  • Causal interaction theory provides a framework for understanding complex relationships.
  • Detecting interference is crucial in settings with potential spillover effects.

Purpose of the Study:

  • To establish the relationship between causal interactions and interference.
  • To demonstrate how empirical tests for causal interactions can be adapted for interference.
  • To provide a conceptual framework for assessing various forms of interference.

Main Methods:

  • Adapting empirical tests for causal interactions to detect interference.
  • Recoding response variables as functions of cluster outcomes.
  • Extending the framework to n-way interactions and multivalued exposures.

Main Results:

  • Empirical tests for causal interactions are directly applicable to detecting interference.
  • A wide range of interference forms can be detected by recoding outcomes.
  • The theory of causal interactions offers a comprehensive approach to assessing interference.

Conclusions:

  • Causal interaction theory provides a robust framework for understanding and quantifying interference.
  • This approach is applicable to vaccine trials and other settings with spillover effects.
  • The findings refine conceptualizations of interaction and enhance the analysis of real-world data.